miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

Lung adenocarcinoma (LUAD) is one of the most common malignancies worldwide. Combination chemotherapy with cisplatin (CDDP) plus pemetrexed (PEM) remains the predominant therapeutic regimen; however, chemoresistance greatly limits its curative potential. Here, through CRISPR-Cas9 screening, we ident...

Full description

Saved in:
Bibliographic Details
Main Authors: Guoshu Bi (Author), Jiaqi Liang (Author), Mengnan Zhao (Author), Huan Zhang (Author), Xing Jin (Author), Tao Lu (Author), Yuansheng Zheng (Author), Yunyi Bian (Author), Zhencong Chen (Author), Yiwei Huang (Author), Valeria Besskaya (Author), Cheng Zhan (Author), Qun Wang (Author), Lijie Tan (Author)
Format: Book
Published: Elsevier, 2022-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available